Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Regeneron Pharmaceuticals Inc. buy Royal Bank of Canada

Regeneron Pharmaceuticals Inc.
Start price
€871.20
09.04.24 / 50%
Target price
€1,092.5
09.04.25
Performance (%)
-4.36%
Price
€833.20
29.04.24
Summary
This prediction is currently active. With a performance of -4.36%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 09.04.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this prediction

Regeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.

Performance without dividends (%)
Name 1w
Regeneron Pharmaceuticals Inc. -1.396%
iShares Core DAX® 0.961%
iShares Nasdaq 100 2.626%
iShares Nikkei 225® 0.217%
iShares S&P 500 1.540%

Comments by Royal_Bank_of_Canada for this prediction

In the thread Regeneron Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -4.36%
Target price 1092.453
Change
Ends at 09.04.25

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $1,189.00 price target on the stock.
Ratings data for REGN provided by MarketBeat

Royal Bank of Canada 
0
Report Share
09.04.24

Stopped prediction by Royal_Bank_of_Canada for Regeneron Pharmaceuticals Inc.

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€911.50
27.02.24
€1,091.9
27.02.25
-8.59%
29.04.24

Royal Bank of Canada 
27.02.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€868.50
05.02.24
€1,034.6
05.02.25
-4.06%
29.04.24

Royal Bank of Canada 
05.02.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€877.50
29.01.24
€995.08
29.01.25
-5.05%
29.04.24

Royal Bank of Canada 
29.01.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€850.00
12.01.24
€981.74
12.01.25
-1.98%
29.04.24

Royal Bank of Canada 
12.01.24 50%